Iovance Biotherapeutics is at the forefront of developing innovative tumor infiltrating lymphocyte (TIL) therapy, aimed at transforming cancer treatment by leveraging the human immune system's ability to identify and target various cancer cells. Our distinctive approach harnesses promising clinical data to advance life-saving immunotherapies for patients with cancer, while continuously pushing the boundaries of cell therapy and exploring gene-edited solutions.
No jobs found. Subscribe below to get notified when we find something for you.
Searching